Study of the Use of Venetoclax in Participants With Chronic Lymphocytic Leukemia (CLL) Under Real-Life Setting
Clinical trial NCT03342144 · RECRUITING
Trial details
- NCT number
- NCT03342144
- Sponsor
- AbbVie
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2017-12-04
- Primary completion
- 2030-12-01
- Enrollment
- 500
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.